These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12753867)

  • 41. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation.
    Vrahnas C; Pearson TA; Brunt AR; Forwood MR; Bambery KR; Tobin MJ; Martin TJ; Sims NA
    Bone; 2016 Dec; 93():146-154. PubMed ID: 27686599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
    Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
    J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.
    Yao W; Hadi T; Jiang Y; Lotz J; Wronski TJ; Lane NE
    Osteoporos Int; 2005 Dec; 16(12):1939-47. PubMed ID: 16086094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone.
    Turner RT; Lotinun S; Hefferan TE; Morey-Holton E
    J Appl Physiol (1985); 2006 Sep; 101(3):881-6. PubMed ID: 16675609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parathyroid hormone 1-84 targets bone vascular structure and perfusion in mice: impacts of its administration regimen and of ovariectomy.
    Roche B; Vanden-Bossche A; Malaval L; Normand M; Jannot M; Chaux R; Vico L; Lafage-Proust MH
    J Bone Miner Res; 2014 Jul; 29(7):1608-18. PubMed ID: 24496950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner.
    Mosekilde L; Thomsen JS; Orhii PB; Kalu DN
    Bone; 1998 Oct; 23(4):343-52. PubMed ID: 9763146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.
    Kostenuik PJ; Ferrari S; Pierroz D; Bouxsein M; Morony S; Warmington KS; Adamu S; Geng Z; Grisanti M; Shalhoub V; Martin S; Biddlecome G; Shimamoto G; Boone T; Shen V; Lacey D
    J Bone Miner Res; 2007 Oct; 22(10):1534-47. PubMed ID: 17576164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M; Zeng GQ; Rowley E; Turner CH
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone.
    Callaci JJ; Juknelis D; Patwardhan A; Wezeman FH
    Alcohol Clin Exp Res; 2006 Apr; 30(4):665-72. PubMed ID: 16573585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats.
    Zhang L; Endo N; Yamamoto N; Tanizawa T; Takahashi HE
    Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats.
    Wronski TJ; Yen CF
    Bone; 1994; 15(1):51-8. PubMed ID: 8024852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of clodronate treatment on established bone loss in ovariectomized rats.
    Kippo K; Hannuniemi R; Laurén L; Peng Z; Kuurtamo P; Virtamo T; Isaksson P; Osterman T; Väänänen HK; Sellman R
    Bone; 1998 Oct; 23(4):333-42. PubMed ID: 9763145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-magnitude whole-body vibration does not enhance the anabolic skeletal effects of intermittent PTH in adult mice.
    Lynch MA; Brodt MD; Stephens AL; Civitelli R; Silva MJ
    J Orthop Res; 2011 Apr; 29(4):465-72. PubMed ID: 21337386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
    Sato M; Ma YL; Hock JM; Westmore MS; Vahle J; Villanueva A; Turner CH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):304-13. PubMed ID: 12065731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice.
    Andersson N; Lindberg MK; Ohlsson C; Andersson K; Ryberg B
    J Endocrinol; 2001 Sep; 170(3):529-37. PubMed ID: 11524233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.